Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Olive oil phenols and neuroprotection.
MS and NMO: Partners No More.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Active Biotech announce that European Medicines Agency accepts start of scientific review of the marketing authorization application for laquinimod in relapsing-remitting multiple sclerosis
Validity and Reliability of a Persian Translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
Corticosteroids for treating optic neuritis.
Oligodendrocytes and the early multiple sclerosis lesion.
Oligodendrocytes Enforce Immune Tolerance of the Uninfected Brain by Purging the Peripheral Repertoire of Autoreactive CD8(+) T Cells.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
Focused suggestion with somatic anchoring technique: rapid self-hypnosis for pain management.
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Ocrelizumab in multiple sclerosis: risks and benefits.
Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
Severe haematological complications during treatment with natalizumab.
Association Between Multiple Sclerosis and Erectile Dysfunction: A Nationwide Case-Control Study.

Pages